Alan F. List

Hematology

12902 Usf Magnolia Dr
Tampa, FL 33612

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 210 publications

Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS).

Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS).

Journal: HemaSphere

Published: October 21, 2025

Long-term follow-up and combined Phase 2 results of eprenetapopt and azacitidine in patients with TP53 mutant MDS/AML.

Long-term follow-up and combined Phase 2 results of eprenetapopt and azacitidine in patients with TP53 mutant MDS/AML.

Journal: HemaSphere

Published: January 02, 2025

Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes.

Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes.

Journal: The Lancet. Haematology

Published: May 20, 2024

Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement.

Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement.

Journal: Blood

Published: May 20, 2024

Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes-Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS]).

Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes-Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS]).

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: April 21, 2024

Resilience in Older Adults Diagnosed With Cancer and Receiving Chemotherapy.

Resilience in Older Adults Diagnosed With Cancer and Receiving Chemotherapy.

Journal: Clinical journal of oncology nursing

Published: September 20, 2023

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS).

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS).

Journal: Blood reviews

Published: May 26, 2023

RAS-pathway mutations are common in patients with ruxolitinib refractory/intolerant myelofibrosis: molecular analysis of the PAC203 cohort.

RAS-pathway mutations are common in patients with ruxolitinib refractory/intolerant myelofibrosis: molecular analysis of the PAC203 cohort.

Journal: Leukemia

Published: March 28, 2023

Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS).

Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS).

Journal: Blood reviews

Published: January 10, 2023

A Proactive Approach to Prevent Hematopoietic Exhaustion During Cancer Chemotherapy in Older Patients: Temporary Cell-Cycle Arrest.

A Proactive Approach to Prevent Hematopoietic Exhaustion During Cancer Chemotherapy in Older Patients: Temporary Cell-Cycle Arrest.

Journal: Drugs & aging

Published: December 27, 2022

Cell cycle arrest: A breakthrough in the supportive care of older cancer patients.

Cell cycle arrest: A breakthrough in the supportive care of older cancer patients.

Journal: Journal of the American Geriatrics Society

Published: December 16, 2022

Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes.

Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes.

Journal: International journal of molecular sciences

Published: December 06, 2022

Showing 1-12 of 210

Last Updated: 09/26/2026